Cantor Fitzgerald reaffirmed their buy rating on shares of Centene (NYSE:CNC) in a research note issued to investors on Sunday, AnalystRatings.com reports. They currently have a $83.00 price objective on the stock.

Several other research analysts also recently commented on the company. ValuEngine downgraded Centene from a sell rating to a strong sell rating in a report on Thursday, April 18th. Zacks Investment Research downgraded Centene from a strong-buy rating to a hold rating in a report on Monday, April 15th. Cowen reissued a buy rating and issued a $77.00 target price on shares of Centene in a report on Sunday, March 31st. Credit Suisse Group reduced their price objective on Centene from $76.00 to $63.00 and set a neutral rating on the stock in a report on Friday, March 29th. Finally, Argus downgraded Centene to a hold rating in a report on Friday, March 29th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus price target of $76.87.

Shares of CNC opened at $50.31 on Friday. The company has a market capitalization of $19.92 billion, a PE ratio of 14.21, a price-to-earnings-growth ratio of 0.85 and a beta of 1.26. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.00 and a current ratio of 1.00. Centene has a one year low of $45.44 and a one year high of $74.49.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, April 23rd. The company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.35 by $0.04. The business had revenue of $18.44 billion for the quarter, compared to the consensus estimate of $17.44 billion. Centene had a return on equity of 14.10% and a net margin of 1.50%. Centene’s revenue was up 39.8% compared to the same quarter last year. During the same period in the previous year, the business earned $2.17 EPS. On average, sell-side analysts expect that Centene will post 4.24 EPS for the current fiscal year.

In other Centene news, EVP Christopher D. Bowers sold 9,200 shares of the company’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $65.01, for a total transaction of $598,092.00. The transaction was disclosed in a filing with the SEC, which is available at this link. 2.50% of the stock is currently owned by corporate insiders.

Institutional investors have recently modified their holdings of the business. Public Employees Retirement System of Ohio raised its position in shares of Centene by 5.9% during the 4th quarter. Public Employees Retirement System of Ohio now owns 85,746 shares of the company’s stock valued at $9,887,000 after acquiring an additional 4,781 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in shares of Centene during the 4th quarter valued at $468,000. Deltec Asset Management LLC bought a new stake in shares of Centene during the 1st quarter valued at $12,458,000. CI Investments Inc. raised its position in shares of Centene by 35.6% during the 4th quarter. CI Investments Inc. now owns 261,900 shares of the company’s stock valued at $30,197,000 after acquiring an additional 68,800 shares during the last quarter. Finally, CWM Advisors LLC raised its position in shares of Centene by 12.2% during the 4th quarter. CWM Advisors LLC now owns 3,939 shares of the company’s stock valued at $454,000 after acquiring an additional 428 shares during the last quarter. Institutional investors own 45.57% of the company’s stock.

About Centene

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.

Featured Article: What is range trading?

Analyst Recommendations for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.